Lead sponsor
Johns Hopkins University
14 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
14
Trials led
6
Ongoing
687
Total enrollment
17
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Phase 1/2
1
Phase 2
6
Phase 2/3
1
Phase 4
3
Not applicable
2
Trials by status
Not yet recruiting
1
Recruiting
5
Completed
7
Withdrawn
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)Age 50-85Ph 2Completed96
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaAge ≥45Ph 2Recruiting50
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseMMSE ≥18Early Ph 1Recruiting20
Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and DementiaStudy partner/caregiver requiredN/ACompleted20
Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)Symptomatic FTDPh 4Withdrawnnot disclosed